CTOs on the Move


 
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.geron.com
  • 149 Commonwealth Drive
    Menlo Park, CA USA 94025
  • Phone: 650.473.7700

Executives

Name Title Contact Details
Brian Blood
Vice President Information Technology Profile
Andrew Grethlein
Executive Vice President and Chief Operating Officer Profile

Similar Companies

Relatient

RELATIENT mobilizes existing, real-time healthcare data to automatically build relationships and promote loyalty with the healthcare consumer, drive compliance and adherence, boost revenue, lower costs, and build lasting relationships like no other Patient Engagement and Messaging platform available today. Compatible with most EHR/PM system on the market, RELATIENT boosts productivity by completely automating necessary outreach in the categories of Appointments, Patient Payments, Health Maintenance, Satisfaction Surveys, Self-Scheduling, and Demand messaging to patients. Reach out to us, you`ll be glad you did!

Biodenix Technologies

Biodenix Technologies Inc. is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radiology Imaging Associates (R.I.A.)

Radiology Imaging Associates (R.I.A.) is a Clinton, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medicare Rights Center

Medicare Rights Center is a Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.